IRADIMED CORPORATION (IRMD) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
IRADIMED CORPORATION (IRMD) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current assets$86.72 MCurrent liabilities$9.16 MAssets$114.98 MLiabilities$13.23 MNon-current liabilities$4.06 MEquity$101.75 MNon-current assets$28.25 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsAccounts receivable, net of allowance for credit losses of $174,138 as of June 30, 2026, and $190,686 as of December 31, 2025Inventory, netPrepaid expenses and other current assetsPrepaid income taxesProperty and equipment, netIntangible assets, netDeferred tax asset, netOther assetsDeferred revenueAccrued payroll and benefitsAccounts payableOther accrued taxesWarranty reserveDeferred revenue, non-currentRetained earningsAdditional paid-in capitalCommon stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,786,740 shares issued and outstanding as of June 30, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityDeferred revenueDeferred revenue$3.47 MCurrent assetsCurrent assets$86.72 MAccrued payroll and benefitsAccrued payroll and benefits$3.06 MCurrent liabilitiesCurrent liabilities$9.16 MAccounts payableAccounts payable$1.85 MCash and cash equivalentsCash and cash equivalents$59.08 MAssetsAssets$114.98 MLiabilitiesLiabilities$13.23 MOther accrued taxesOther accrued taxes$641.00 KWarranty reserveWarranty reserve$146.00 KAccounts receivable, net of allowance for credit losses of $174,138 as of June 30, 2026, and $190,686 as of December 31, 2025Accounts receivable, net$13.19 MNon-current liabilitiesNon-current liabilities$4.06 MDeferred revenue, non-currentDeferred revenue, non-current$4.06 MInventory, netInventory, net$12.26 MEquityEquity$101.75 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$1.40 MPrepaid income taxesPrepaid income taxes$792.00 KRetained earningsRetained earnings$70.15 MNon-current assetsNon-current assets$28.25 MProperty and equipment, netProperty and equipment, net$24.21 MIntangible assets, netIntangible assets, net$3.44 MAdditional paid-in capitalAdditional paid-in capital$31.59 MDeferred tax asset, netDeferred tax asset, net$363.00 KOther assetsOther assets$244.00 KCommon stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,786,740 shares issued and outstanding as of June 30, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025Common stock$1.00 K
Chart details

IRADIMED CORPORATION (IRMD) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
114,975,000 US dollars
Current assets
86,722,000 US dollars
Non-current assets
28,253,000 US dollars
Liabilities
13,227,000 US dollars
Current liabilities
9,164,000 US dollars
Non-current liabilities
4,063,000 US dollars
Equity
101,748,000 US dollars
Cash and cash equivalents
59,080,000 US dollars
Accounts receivable, net of allowance for credit losses of $174,138 as of June 30, 2026, and $190,686 as of December 31, 2025
13,192,000 US dollars
Inventory, net
12,257,000 US dollars
Prepaid expenses and other current assets
1,401,000 US dollars
Prepaid income taxes
792,000 US dollars
Property and equipment, net
24,208,000 US dollars
Intangible assets, net
3,438,000 US dollars
Deferred tax asset, net
363,000 US dollars
Other assets
244,000 US dollars
Deferred revenue
3,469,000 US dollars
Accrued payroll and benefits
3,059,000 US dollars
Accounts payable
1,849,000 US dollars
Other accrued taxes
641,000 US dollars
Warranty reserve
146,000 US dollars
Accrued income taxes
0 US dollars
Deferred revenue, non-current
4,063,000 US dollars
Retained earnings
70,154,000 US dollars
Additional paid-in capital
31,593,000 US dollars
Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,786,740 shares issued and outstanding as of June 30, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025
1,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
IRADIMED CORPORATION (IRMD) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!